Original Article | Published:

Epidemiology and Population Health

Long-term health outcomes in patients with Prader–Willi Syndrome: a nationwide cohort study in Denmark

International Journal of Obesity volume 41, pages 15311538 (2017) | Download Citation

Abstract

Background:

Prader–Willi syndrome (PWS) is a rare congenital disease that affects growth, sexual development, cognitive function and behavior. Individuals exhibit food preoccupation and hyperphagia, which may lead to obesity with premature morbidity and mortality. The aim of this work was to evaluate the risk of venous thromboembolisms (VTEs), myocardial infarction, pulmonary hypertension, sleep apnea, depression, anxiety and all-cause mortality among persons with PWS as compared with an age- and sex-matched general-population cohort.

Methods:

All persons diagnosed with PWS (n=155) were identified in the Danish Health Registries; an age- and sex-matched comparison group was selected from the general population of Denmark (n=15 500); diseases of interest were identified through the health registry and cause of death register. Follow-up began on date of birth or first medical record availability through to first occurrence of an outcome of interest; follow-up ceased at emigration from Denmark or end of study. Incidence rates (IRs) were calculated and Cox's proportional hazards models were used to understand the relative risk (RR) of disease.

Results:

The IRs for VTE among patients with PWS was 144 (60–347) per 100 000 person-years. Risks for VTE events and all-cause mortality were 9.4 times (95% confidence interval (CI): 3.7–23.5) and 11.0 times (95% CI: 5.7–21.1) higher, respectively, for patients with PWS versus the general population. Increased risks were also found individually for deep venous thromboses (DVTs) (RR: 9.1; 95% CI: 3.2–25.2), pulmonary embolisms (RR: 11.0; 95% CI: 1.4–86.9), myocardial infarction (RR: 7.2; 95% CI: 1.7–30.2) and anxiety (RR: 2.8; 95% CI: 1.0–7.5). No cases of pulmonary hypertension, sleep apnea or depressive disorders were identified within this PWS cohort.

Conclusions:

Multiple cardiovascular and behavioral illnesses are more likely to occur among patients with PWS than within the general population. These increased risks may provide an impetus for enhanced disease prevention, screening, diagnosis and treatment.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    . Prader–Willi syndrome: obesity due to genomic imprinting. Curr Genomics 2011; 12: 204–215.

  2. 2.

    , , , Health Care for People with Intellectual and Developmental Disabilities Across the Lifespan, 2016. Available at: (last accessed 6 October 2016).

  3. 3.

    , , . Frequency of the Prader–Willi syndrome in the San-in district, Japan. Brain Dev 1995; 17: 324–326.

  4. 4.

    , , , . A population-based profile of 160 Australians with Prader–Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics. Am J Med Genet 2015; 167A: 371–378.

  5. 5.

    , , , , , . Population prevalence and estimated birth incidence and mortality rate for people with Prader–Willi syndrome in one UK Health Region. J Med Genet 2001; 38: 792–798.

  6. 6.

    , , . A long-term population-based clinical and morbidity review of Prader–Willi syndrome in Western Australia. J Intellect Disabil Res 2006; 50: 69–78.

  7. 7.

    , , . Prader–Willi syndrome in a Swedish rural county: epidemiological aspects. Dev Med Child Neurol 1991; 33: 715–721.

  8. 8.

    , , , , , et al. Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders. Eur J Hum Genet 2004; 12: 238–240.

  9. 9.

    , . Genetic obesity syndromes. Front Horm Res 2008; 36: 37–60.

  10. 10.

    , , . Development of the eating behaviour in Prader–Willi syndrome: advances in our understanding. Int J Obes 2005 2011; 35: 188–197.

  11. 11.

    , , . Prader–Willi syndrome: from genetics to behaviour, with special focus on appetite treatments. Neurosci Biobehav Rev 2015; 59: 155–172.

  12. 12.

    , , , , , et al. Clinical aspects of obesity in childhood and adolescence. Obes Rev Off J Int Assoc Study Obes 2001; 2: 29–36.

  13. 13.

    , , , . The prevalence of metabolic risk factors of atherosclerotic cardiovascular disease in Williams syndrome, Prader–Willi syndrome, and Down syndrome. J Intellect Dev Disabil 2016; 41: 187–196.

  14. 14.

    , , . Three siblings with Prader–Willi syndrome: brief review of sleep and Prader–Willi syndrome. Case Rep Neurol Med 2015; 2015: 278–287.

  15. 15.

    , , , , , et al. Prevalence of diagnosed sleep disorders and related diagnostic and surgical procedures in children with autism spectrum disorders. J Dev Behav Pediatr 2016; 37: 377–384.

  16. 16.

    , , , , , . Prader–Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 2004; 124A: 333–338.

  17. 17.

    , , , , , et al. Cause of sudden, unexpected death of Prader–Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005; 136: 45–48.

  18. 18.

    , , , , , et al. Growth hormone treatment and adverse events in Prader–Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf) 2006; 65: 178–185.

  19. 19.

    , , , , , . Mortality in Prader–Willi syndrome. Am J Ment Retard 2006; 111: 193–198.

  20. 20.

    , , . Prader–Willi syndrome in Victoria: mortality and causes of death. J Paediatr Child Health 2012; 48: 506–511.

  21. 21.

    , (eds.) Psychiatric and Behavioural Disorders in Intellectual and Developmental Disabilities, 2nd edn. Cambridge University Press: Cambridge, NY, USA, 2007.

  22. 22.

    , . Prader–Willi syndrome: systematic review of the prevalence and nature of presentation of unipolar depression. Adv Ment Health Intellect Disabil 2016; 10: 172–184.

  23. 23.

    . Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398–2399.

  24. 24.

    , , . The Danish Health Care System: evolution—not revolution—in a decentralized system. Health Econ 2005; 14: S41–S57.

  25. 25.

    , , , , . The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263–268.

  26. 26.

    , , , . The Danish Cancer Registry—history, content, quality and use. Dan Med Bull 1997; 44: 535–539.

  27. 27.

    , , , , , . The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449–490.

  28. 28.

    , . Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162: 975–982.

  29. 29.

    , , , , . Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet Lond Engl 2007; 370: 1773–1779.

  30. 30.

    . Death in adults with Prader–Willi syndrome may be correlated with maternal uniparental disomy. J Med Genet 2003; 40: 63e–63e.

  31. 31.

    Update from the Prader–Willi Syndrome Association USA Study of Death Committee, 2015. Available from: .

  32. 32.

    , , , , . Causes of death in Prader–Willi syndrome: Prader–Willi Syndrome Association (USA) 40-year mortality survey. Genet Med Off J Am Coll Med Genet 2016; 19: 635–642.

  33. 33.

    , , . Delay and misdiagnosis in sub-massive and non-massive acute pulmonary embolism. Eur J Intern Med 2010; 21: 278–282.

  34. 34.

    , , . Risk factors associated with delayed diagnosis of acute pulmonary embolism. J Emerg Med 2012; 42: 1–6.

  35. 35.

    , , , , , . Pulmonary embolism in adolescents. Chin Med J (Engl) 2012; 125: 1089–1094.

  36. 36.

    , , , , , et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251–1257.

  37. 37.

    Office of the Surgeon General (US), National Heart, Lung, and Blood Institute (US)The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Office of the Surgeon General (US): Rockville, MD, USA, 2008. Available at: (accessed 5 July 2016).

  38. 38.

    , . Sporadic registration of obesity as secondary diagnosis. Ugeskr Laeger 2002; 164: 3193–3195.

  39. 39.

    , , , . Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res 2014; 14: 70.

  40. 40.

    , , , . Weighty problems: predictors of family physicians documenting overweight and obesity. Fam Med 2016; 48: 217–221.

  41. 41.

    , , , , , et al. Coronary artery dissection in Prader–Willi syndrome: case report and literature review. Can J Cardiol 2012; 28: 759.e9–759.e11.

  42. 42.

    , , , . Premature coronary artery disease and the Prader–Willi syndrome. Postgrad Med J 1990; 66: 232–234.

  43. 43.

    , . Premature coronary artery atherosclerosis in a patient with Prader–Willi syndrome. Am J Med Genet 1987; 28: 873–880.

  44. 44.

    , . Emotional symptoms in Prader–Willi syndrome adolescents. Am J Med Genet 1987; 28: 897–905.

  45. 45.

    , , , , . Behavioral characteristics of Prader–Willi syndrome in Korea: comparison with children with mental retardation and normal controls. J Child Neurol 2005; 20: 134–138.

  46. 46.

    , , , , , . Prader–Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry J Ment Sci 2002; 180: 358–362.

  47. 47.

    , , . Prader–Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population. J Clin Sleep Med 2014; 10: 403–409.

  48. 48.

    , , , , . The Danish National Database for Obstructive Sleep Apnea. Clin Epidemiol 2016; 8: 573–576.

  49. 49.

    , , , , , . The use of medical care and the prevalence of serious illness in an adult Prader–Willi syndrome cohort. Eur J Med Genet 2013; 56: 397–403.

  50. 50.

    , , , , , et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol 2010; 149: 273–279.

  51. 51.

    , , , , , et al. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open 2013; 3: 1–11.

  52. 52.

    , , , , , . Diagnosed anxiety disorders and the risk of subsequent anorexia nervosa: a Danish Population Register Study. Eur Eat Disord Rev 2015; 23: 524–530.

  53. 53.

    , , , , , Danish Childhood Diabetes Registry. Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes 2009; 10: 248–254.

  54. 54.

    , , , . Analyses of data quality in registries concerning diabetes mellitus—a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst 1996; 20: 1–10.

  55. 55.

    , . Using registries to identify type 2 diabetes patients. Clin Epidemiol 2015; 7: 1–3.

Download references

Author information

Affiliations

  1. Department of Epidemiology, EpidStat Inst, Ann Arbor, MI, USA

    • E Hedgeman
    •  & J Fryzek
  2. Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus C, Denmark

    • S P Ulrichsen
    •  & M S Olsen
  3. Coté Orphan LLC, Silver Spring, MD, USA

    • S Carter
  4. Zafgen Inc., Boston, MA, USA

    • N C Kreher
    •  & K P Malobisky
  5. Miles Health LLC, North Potomac, MD, USA

    • M M Braun

Authors

  1. Search for E Hedgeman in:

  2. Search for S P Ulrichsen in:

  3. Search for S Carter in:

  4. Search for N C Kreher in:

  5. Search for K P Malobisky in:

  6. Search for M M Braun in:

  7. Search for J Fryzek in:

  8. Search for M S Olsen in:

Competing interests

At the time of this work, Drs Malobisky and Kreher were employees of Zafgen; Dr Malobisky has financial holdings in Zafgen. Dr Fryzek, Ms Carter and Dr Hedgeman have received compensation as consultants for Zafgen. Dr Braun has received compensation as a consultant for EpidStat.

Corresponding author

Correspondence to E Hedgeman.

Supplementary information

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/ijo.2017.139